Frederick R. Ueland, MD

  • Chief, Division of Gynecologic Oncology
  • Vice Chair, Department of Obstetrics and Gynecology
  • Director, MCC Oncology Clinical Operations
  • Fellowship Director


Frederick Ueland is a graduate of Stanford University and received his medical degree from the Wake Forest University, School of Medicine, Winston-Salem, N.C. He then completed a fellowship in Gynecologic Oncology at the University of Kentucky, Lexington. He is board certified by the American Board of Obstetrics and Gynecology in Gynecologic Oncology.

Dr. Ueland's special interests include ovarian tumor evaluation with ultrasound and biomarkers, treatment of ovarian cancer, and advanced pelvic surgery. He is an active translational researcher at the NCI-designated Markey Cancer Center, and was the principal investigator for the OVA-1 trial which resulted in FDA-clearance for the ovarian tumor blood test in 2009. He is also the Medical Director of Gynecologic Surgery, and Medical Director of Outpatient Chemotherapy and Infusion for UK HealthCare. He serves on a number of local and national cancer committees.

Faculty Rank

  • Professor of Obstetrics and Gynecology
  • fixes empty view field issue

    Linda Young talks about her tumor and her experience with Dr. Ueland

    Linda Young had a football-sized tumor in her abdomen. This is her story.

Training & Education


Wake Forest University, School of Medicine, Winston-Salem, N.C.


University of Kentucky, Lexington


University of Kentucky, Lexington

Certifications and Special Training

American Board of Obstetrics and Gynecology
American Board of Obstetrics and Gynecology, Gynecologic Oncology

Insurance Information

Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs.

See list of insurers